Epigenetic changes at the locus in FSHD may reveal binding sites in DME1/2 for myogenic regulatory factors and PAX proteins such as PAX3 and PAX7, which could then facilitate DUX4 expression in myofibres and muscle stem cells (satellite cells). The gene discussed is PAX3; the disease is Facioscapulohumeral dystrophy.